4//SEC Filing
Wilson Marc 4
Accession 0000950170-24-110416
CIK 0001658247other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 5:01 PM ET
Size
8.8 KB
Accession
0000950170-24-110416
Insider Transaction Report
Form 4
Wilson Marc
CFO
Transactions
- Sale
Common Stock
2024-09-26$51.11/sh−25,000$1,277,750→ 111,092 total - Exercise/Conversion
Common Stock
2024-09-26$15.29/sh+25,000$382,250→ 136,092 total - Exercise/Conversion
Stock option (Right to Buy)
2024-09-26−25,000→ 89,000 totalExercise: $15.29Exp: 2031-02-26→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $51.11 per share. The range of sales prices on the transaction date was $50.28 to $51.54 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
- [F3]1/48th of the shares subject to the option vested on March 26, 2021, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001702265
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 5:01 PM ET
- Size
- 8.8 KB